Adverse Reactions Clinical Trials Experience The most commonly reported adverse reactions are hypersensitivity (e.g., rash, urticaria) reactions due to the effect of GH (e.g., arthralgia, extremity pain, peripheral edema, hyperglycemia, carpal tunnel syndrome), injection site reactions (injection site erythema, pruritis, pain, urticaria, irritation, swelling, hemorrhage)
It is just no longer the leading-edge clinical tool for most goals in 2026, which is why most modern medical clinics, including ours, have moved on to Tesamorelin (for visceral fat) and CJC-1295/Ipamorelin (for broader GH optimization)
47 OgunniyiD
DOI:10.1007/s11033-012-2109-7 [ Links ] 48
More specifically, Ipamorelin appeared to have tended to boost growth hormone levels, potentially soaring to as much as 80mIU/l (roughly equivalent to a concentration of about 26.6ng/ml)